Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+
Virginia Commonwealth University
Virginia Commonwealth University
Stichting Hemato-Oncologie voor Volwassenen Nederland
Memorial Sloan Kettering Cancer Center
University Health Network, Toronto
The First Affiliated Hospital of Soochow University
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Florida International University
Ain Shams University
The First Affiliated Hospital of Xiamen University
The First Affiliated Hospital of Xiamen University
Ruijin Hospital
University Medical Center Groningen
Zhejiang Provincial People's Hospital
University Medical Center Goettingen
Australasian Leukaemia and Lymphoma Group
Peking Union Medical College Hospital